These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 31637971

  • 1. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
    Leitão L, Soares-Dos-Reis R, Neves JS, Baptista RB, Bigotte Vieira M, Mc Causland FR.
    Stroke; 2019 Dec; 50(12):3639-3642. PubMed ID: 31637971
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Zhang L, Sun X, Liao L, Zhang S, Zhou H, Zhong X, Zhuang X, Liao X.
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
    [Abstract] [Full Text] [Related]

  • 3. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.
    Foy CG, Lovato LC, Vitolins MZ, Bates JT, Campbell R, Cushman WC, Glasser SP, Gillespie A, Kostis WJ, Krousel-Wood M, Muhlestein JB, Oparil S, Osei K, Pisoni R, Segal MS, Wiggers A, Johnson KC, SPRINT Study Research Group.
    J Hypertens; 2018 Apr; 36(4):904-915. PubMed ID: 29493562
    [Abstract] [Full Text] [Related]

  • 4. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
    Parcha V, Patel N, Kalra R, Kim J, Gutiérrez OM, Arora G, Arora P.
    Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
    [Abstract] [Full Text] [Related]

  • 5. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE, SPRINT Research Study Group.
    Circulation; 2017 Aug 01; 136(5):440-450. PubMed ID: 28512184
    [Abstract] [Full Text] [Related]

  • 6. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT.
    Chang AR, Kramer H, Wei G, Boucher R, Grams ME, Berlowitz D, Bhatt U, Cohen DL, Drawz P, Punzi H, Freedman BI, Haley W, Hawfield A, Horwitz E, McLouth C, Morisky D, Papademetriou V, Rocco MV, Wall B, Weiner DE, Zias A, Beddhu S, for the SPRINT Research Group .
    Clin J Am Soc Nephrol; 2020 Aug 07; 15(8):1121-1128. PubMed ID: 32669306
    [Abstract] [Full Text] [Related]

  • 7. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
    Still CH, Rodriguez CJ, Wright JT, Craven TE, Bress AP, Chertow GM, Whelton PK, Whittle JC, Freedman BI, Johnson KC, Foy CG, He J, Kostis JB, Lash JP, Pedley CF, Pisoni R, Powell JR, Wall BM, SPRINT Writing Group.
    Am J Hypertens; 2017 Dec 08; 31(1):97-107. PubMed ID: 28985268
    [Abstract] [Full Text] [Related]

  • 8. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S, Chertow GM, Cheung AK, Cushman WC, Rahman M, Greene T, Wei G, Campbell RC, Conroy M, Freedman BI, Haley W, Horwitz E, Kitzman D, Lash J, Papademetriou V, Pisoni R, Riessen E, Rosendorff C, Watnick SG, Whittle J, Whelton PK, SPRINT Research Group.
    Circulation; 2018 Jan 09; 137(2):134-143. PubMed ID: 29021322
    [Abstract] [Full Text] [Related]

  • 9. Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
    Agarwal A, Cheung AK, Ma J, Cho M, Li M.
    J Am Heart Assoc; 2019 Aug 20; 8(16):e013098. PubMed ID: 31423869
    [Abstract] [Full Text] [Related]

  • 10. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF, Vehmeijer JT, Kalkman DN, Berger WR, van den Born BH, Peters RJ, Knops RE.
    Diabetes Care; 2018 Jun 20; 41(6):1142-1148. PubMed ID: 29212825
    [Abstract] [Full Text] [Related]

  • 11. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X, Guo Y, Nie Z, Cheng J, Zhou H, Zhong X, Zhang S, Du Z, Zhuang X, Liao X.
    Clin Res Cardiol; 2019 Mar 20; 108(3):273-281. PubMed ID: 30167807
    [Abstract] [Full Text] [Related]

  • 12. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, Bates JT, Bello NA, Aurigemma G, Fine LJ, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW, SPRINT Research Group.
    Circ Heart Fail; 2017 Apr 20; 10(4):. PubMed ID: 28364091
    [Abstract] [Full Text] [Related]

  • 13. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT.
    Sobieraj P, Lewandowski J, Siński M, Symonides B, Gaciong Z.
    J Am Heart Assoc; 2019 Feb 19; 8(4):e010811. PubMed ID: 30744452
    [Abstract] [Full Text] [Related]

  • 14. Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).
    Chang TI, Reboussin DM, Chertow GM, Cheung AK, Cushman WC, Kostis WJ, Parati G, Raj D, Riessen E, Shapiro B, Stergiou GS, Townsend RR, Tsioufis K, Whelton PK, Whittle J, Wright JT, Papademetriou V, SPRINT Research Group*.
    Hypertension; 2017 Oct 19; 70(4):751-758. PubMed ID: 28760939
    [Abstract] [Full Text] [Related]

  • 15. Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.
    Wang Z, Li W, Jiang C, Wang J, Hua C, Tang Y, Zhang H, Liu X, Wang Y, Gao M, Lv Q, Dong J, Ma C, Du X.
    J Hypertens; 2024 Jul 01; 42(7):1203-1211. PubMed ID: 38690929
    [Abstract] [Full Text] [Related]

  • 16. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
    Lee TC, Cavalcanti RB, McDonald EG, Pilote L, Brophy JM.
    Am J Med; 2018 Oct 01; 131(10):1228-1233.e1. PubMed ID: 29906425
    [Abstract] [Full Text] [Related]

  • 17. Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
    Mok Y, Ballew SH, Sang Y, Grams ME, Coresh J, Evans M, Barany P, Ärnlöv J, Carrero JJ, Matsushita K.
    J Am Heart Assoc; 2019 Apr 16; 8(8):e010546. PubMed ID: 30947615
    [Abstract] [Full Text] [Related]

  • 18. Heart failure and the discrepancy between trials of intensive blood pressure management: an analysis of individual patient data.
    Aggarwal R, Mirzan H, Chiu N, Steinkamp J.
    Clin Res Cardiol; 2018 Jul 16; 107(7):565-569. PubMed ID: 29480390
    [Abstract] [Full Text] [Related]

  • 19. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
    Buckley LF, Dixon DL, Wohlford GF, Wijesinghe DS, Baker WL, Van Tassell BW.
    Diabetes Care; 2017 Dec 16; 40(12):1733-1738. PubMed ID: 28947569
    [Abstract] [Full Text] [Related]

  • 20. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
    Oikonomou EK, Spatz ES, Suchard MA, Khera R.
    Lancet Digit Health; 2022 Nov 16; 4(11):e796-e805. PubMed ID: 36307193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.